nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.0406	0.159	CbGeAlD
Amoxapine—HTR7—sympathetic nervous system—adrenal gland cancer	0.0391	0.153	CbGeAlD
Amoxapine—HTR7—vein—adrenal gland cancer	0.0366	0.143	CbGeAlD
Amoxapine—HTR2A—sympathetic nervous system—adrenal gland cancer	0.0244	0.0954	CbGeAlD
Amoxapine—HTR2A—vein—adrenal gland cancer	0.0228	0.0893	CbGeAlD
Amoxapine—HTR2A—urine—adrenal gland cancer	0.0134	0.0523	CbGeAlD
Amoxapine—CYP2D6—urine—adrenal gland cancer	0.0122	0.0476	CbGeAlD
Amoxapine—HTR2B—adrenal cortex—adrenal gland cancer	0.00664	0.0259	CbGeAlD
Amoxapine—Desloratadine—ABCB1—adrenal gland cancer	0.00654	0.512	CrCbGaD
Amoxapine—SLC6A2—gonad—adrenal gland cancer	0.00488	0.0191	CbGeAlD
Amoxapine—HTR2B—adrenal gland—adrenal gland cancer	0.00479	0.0187	CbGeAlD
Amoxapine—HTR7—gonad—adrenal gland cancer	0.00471	0.0184	CbGeAlD
Amoxapine—DRD2—pituitary gland—adrenal gland cancer	0.00434	0.017	CbGeAlD
Amoxapine—HTR1A—adrenal gland—adrenal gland cancer	0.00429	0.0168	CbGeAlD
Amoxapine—SLC6A2—adrenal gland—adrenal gland cancer	0.00426	0.0166	CbGeAlD
Amoxapine—HTR7—adrenal gland—adrenal gland cancer	0.0041	0.016	CbGeAlD
Amoxapine—ADRA1A—adrenal gland—adrenal gland cancer	0.00396	0.0155	CbGeAlD
Amoxapine—ADRA2A—gonad—adrenal gland cancer	0.00345	0.0135	CbGeAlD
Amoxapine—ADRA2A—cardiac atrium—adrenal gland cancer	0.00345	0.0135	CbGeAlD
Amoxapine—ADRA2A—pituitary gland—adrenal gland cancer	0.00337	0.0132	CbGeAlD
Amoxapine—HRH1—adrenal gland—adrenal gland cancer	0.00306	0.012	CbGeAlD
Amoxapine—ADRA2A—adrenal gland—adrenal gland cancer	0.00301	0.0118	CbGeAlD
Amoxapine—HTR2A—gonad—adrenal gland cancer	0.00293	0.0115	CbGeAlD
Amoxapine—HTR2A—pituitary gland—adrenal gland cancer	0.00286	0.0112	CbGeAlD
Amoxapine—HTR2A—adrenal gland—adrenal gland cancer	0.00256	0.00999	CbGeAlD
Amoxapine—Olanzapine—ABCB1—adrenal gland cancer	0.00235	0.184	CrCbGaD
Amoxapine—Quetiapine—ABCB1—adrenal gland cancer	0.00142	0.111	CrCbGaD
Amoxapine—Diazepam—ABCB1—adrenal gland cancer	0.00124	0.097	CrCbGaD
Amoxapine—Clozapine—ABCB1—adrenal gland cancer	0.00122	0.0958	CrCbGaD
Amoxapine—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000236	0.000323	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000236	0.000323	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	0.000236	0.000322	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.000235	0.000321	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—POMC—adrenal gland cancer	0.000234	0.00032	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000233	0.000319	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000233	0.000318	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000233	0.000318	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000232	0.000317	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000232	0.000317	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000231	0.000316	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000231	0.000316	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000229	0.000313	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000228	0.000312	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000228	0.000311	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000226	0.000309	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000225	0.000308	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CDC42—adrenal gland cancer	0.000225	0.000307	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CDC42—adrenal gland cancer	0.000225	0.000307	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000224	0.000306	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000222	0.000304	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	0.000222	0.000303	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000221	0.000303	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000221	0.000302	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000221	0.000302	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000221	0.000302	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00022	0.000301	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000218	0.000299	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000217	0.000297	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IGF2—adrenal gland cancer	0.000217	0.000296	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IGF2—adrenal gland cancer	0.000216	0.000296	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CDC42—adrenal gland cancer	0.000215	0.000294	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000215	0.000294	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—GNAS—adrenal gland cancer	0.000215	0.000294	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—GNAS—adrenal gland cancer	0.000215	0.000293	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000212	0.000289	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.000211	0.000288	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000211	0.000288	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IGF1R—adrenal gland cancer	0.00021	0.000286	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IGF1R—adrenal gland cancer	0.000209	0.000286	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000209	0.000285	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	0.000208	0.000284	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IGF2—adrenal gland cancer	0.000207	0.000283	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—GNAS—adrenal gland cancer	0.000205	0.000281	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000205	0.000281	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000204	0.000278	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000202	0.000276	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IGF1R—adrenal gland cancer	0.0002	0.000274	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.0002	0.000273	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000199	0.000272	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000198	0.00027	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000196	0.000268	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000196	0.000268	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000195	0.000267	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000194	0.000265	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000191	0.000262	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	0.000191	0.000261	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000187	0.000255	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000185	0.000253	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000184	0.000252	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	0.000184	0.000252	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	0.000182	0.000249	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000181	0.000248	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TERT—adrenal gland cancer	0.00018	0.000247	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00018	0.000247	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.00018	0.000247	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TERT—adrenal gland cancer	0.00018	0.000246	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000178	0.000243	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000175	0.00024	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000175	0.00024	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000174	0.000237	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TERT—adrenal gland cancer	0.000172	0.000236	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000172	0.000236	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000172	0.000236	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000172	0.000235	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000172	0.000235	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000169	0.000232	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000169	0.000231	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000169	0.000231	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000169	0.000231	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000166	0.000228	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000166	0.000227	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000166	0.000226	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000165	0.000225	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	0.000165	0.000225	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.00016	0.000219	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.00016	0.000218	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000159	0.000218	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000159	0.000217	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000158	0.000216	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—BAD—adrenal gland cancer	0.000157	0.000215	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000157	0.000214	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—BAD—adrenal gland cancer	0.000157	0.000214	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000157	0.000214	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.000156	0.000214	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000156	0.000213	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000155	0.000212	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000155	0.000212	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000154	0.000211	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000154	0.000211	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000153	0.00021	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.000153	0.000209	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000152	0.000208	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—BAD—adrenal gland cancer	0.00015	0.000205	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000149	0.000204	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000147	0.000201	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000146	0.0002	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—POMC—adrenal gland cancer	0.000145	0.000198	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—POMC—adrenal gland cancer	0.000144	0.000198	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000144	0.000197	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.000143	0.000196	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	0.000143	0.000196	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000143	0.000196	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	0.000143	0.000195	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	0.000143	0.000195	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000142	0.000195	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000141	0.000193	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000141	0.000192	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000141	0.000192	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.00014	0.000191	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000139	0.00019	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000139	0.000189	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	0.000138	0.000189	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—POMC—adrenal gland cancer	0.000138	0.000189	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	0.000138	0.000189	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000138	0.000189	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000138	0.000188	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—EGFR—adrenal gland cancer	0.000138	0.000188	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000137	0.000188	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000137	0.000187	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000137	0.000187	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	0.000137	0.000187	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000136	0.000186	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000136	0.000186	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000135	0.000185	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000135	0.000184	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000135	0.000184	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000134	0.000183	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000134	0.000183	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000134	0.000183	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000133	0.000182	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—BAD—adrenal gland cancer	0.000133	0.000182	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000133	0.000182	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000132	0.000181	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	0.000132	0.000181	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000131	0.000179	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000131	0.000179	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	0.00013	0.000178	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000126	0.000173	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000126	0.000172	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000125	0.000171	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000125	0.00017	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000123	0.000168	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—POMC—adrenal gland cancer	0.000123	0.000168	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000122	0.000167	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	0.000121	0.000166	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.00012	0.000164	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000119	0.000163	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000118	0.000161	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000118	0.000161	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000117	0.00016	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000116	0.000159	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000116	0.000158	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TP53—adrenal gland cancer	0.000115	0.000158	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000115	0.000158	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.000115	0.000157	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000115	0.000157	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000113	0.000154	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.000107	0.000146	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000107	0.000146	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000106	0.000145	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000105	0.000144	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000105	0.000143	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000103	0.000141	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000103	0.000141	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000102	0.00014	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000102	0.000139	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000102	0.000139	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000101	0.000138	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.0001	0.000137	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.0001	0.000137	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.0001	0.000137	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	9.98e-05	0.000136	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	9.87e-05	0.000135	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	9.82e-05	0.000134	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	9.74e-05	0.000133	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	9.56e-05	0.000131	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	9.42e-05	0.000129	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	9.4e-05	0.000129	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	9.28e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	9.25e-05	0.000126	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	9.23e-05	0.000126	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	9.2e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	9.13e-05	0.000125	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	9.13e-05	0.000125	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	9.11e-05	0.000125	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	9.09e-05	0.000124	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	9.06e-05	0.000124	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	9e-05	0.000123	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	8.94e-05	0.000122	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	8.89e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	8.85e-05	0.000121	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	8.83e-05	0.000121	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	8.81e-05	0.00012	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	8.77e-05	0.00012	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	8.67e-05	0.000119	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	8.42e-05	0.000115	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	8.31e-05	0.000114	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	8.18e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	8.17e-05	0.000112	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	8.05e-05	0.00011	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	8.03e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	7.95e-05	0.000109	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	7.82e-05	0.000107	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.64e-05	0.000104	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	7.6e-05	0.000104	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	7.47e-05	0.000102	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	7.04e-05	9.63e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	6.95e-05	9.5e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—adrenal gland cancer	6.87e-05	9.39e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—adrenal gland cancer	6.86e-05	9.38e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	6.71e-05	9.17e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	6.67e-05	9.12e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.6e-05	9.03e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	6.59e-05	9.01e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	6.57e-05	8.98e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—adrenal gland cancer	6.57e-05	8.98e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—POMC—adrenal gland cancer	6.56e-05	8.97e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.46e-05	8.84e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	6.27e-05	8.57e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	6.05e-05	8.28e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	6.02e-05	8.24e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.01e-05	8.21e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—adrenal gland cancer	5.91e-05	8.08e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—adrenal gland cancer	5.83e-05	7.97e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	5.32e-05	7.27e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	5.23e-05	7.15e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	5.23e-05	7.15e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	5.22e-05	7.14e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	5.2e-05	7.11e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	5.12e-05	7e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	5.08e-05	6.95e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	5.06e-05	6.91e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	4.76e-05	6.51e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	4.46e-05	6.1e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	4.39e-05	6e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	4.38e-05	5.99e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	4.37e-05	5.97e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	4.3e-05	5.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	3.99e-05	5.46e-05	CbGpPWpGaD
